Biapenem reduces sepsis mortality via barrier protective pathways against HMGB1-mediated septic responses-Reference-Cited by-同舟云学术

Biapenem reduces sepsis mortality via barrier protective pathways against HMGB1-mediated septic responses

Published:2021-01-30 Issue: Volume: Page:
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacol. Rep

Author:

Kim Jaehong,Choo Samyeol,Sim Hyunchae,Baek Moon-Chang,Bae Jong-Sup^ORCID

Funder

Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea

National Research Foundation of Korea (NRF) grant funded by the Korean government

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s43440-020-00212-0.pdf

Reference46 articles.

1. Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.

2. Ziesmann MT, Marshall JC. Multiple organ dysfunction: the defining syndrome of sepsis. Surg Infect (Larchmt). 2018;19:184–90.

3. Ologunde R, Zhao H, Lu K, Ma D. Organ cross talk and remote organ damage following acute kidney injury. Int Urol Nephrol. 2014;46:2337–45.

4. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med. 2003;9:517–24.

5. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165:2950–4.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial dysfunction: Pathophysiology and therapeutic targets for sepsis-induced multiple organ dysfunction syndrome;Biomedicine & Pharmacotherapy;2024-09

2. Da-Cheng-Qi decoction improves severe acute pancreatitis-associated acute lung injury by interfering with intestinal lymphatic pathway and reducing HMGB1-induced inflammatory response in rats;Pharmaceutical Biology;2023-01-09

3. Biapenem Activity Against Meropenem-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa;Antibiotics and Chemotherapy;2022-08-05

4. High Mobility Group Proteins in Sepsis;Frontiers in Immunology;2022-06-02